生菜表达嵌合乙肝病毒S/preS1抗原口服可诱导小鼠产生感染中和抗体
研究在生菜中瞬时表达嵌合HBV抗原S/preS121-47,以1 μg/剂、共3次、无佐剂口服免疫小鼠,可触发体液免疫应答,所诱抗体在HepG2-NTCP细胞感染系统中和HBV感染的能力优于口服表达S蛋白的生菜免疫小鼠所诱抗体,支持该抗原作为 edible HBV疫苗候选。
要点
- 生菜表达的无佐剂S/preS121-47抗原按1 μg/剂口服3次即可在小鼠中触发体液免疫应答。
- 所诱抗体在表达NTCP的HepG2-NTCP细胞感染系统中能中和HBV感染。
- 该抗体的中和效率优于口服表达S蛋白的生菜免疫小鼠所诱抗体。
核心结论
- 口服表达S/preS121-47抗原的生菜可诱导小鼠产生能中和HBV感染的抗体,支持该抗原作为未来 edible HBV疫苗开发的候选。
研究设计与样本
- 在食用植物生菜中瞬时表达HBV嵌合抗原S/preS121-47,并以无佐剂方式口服免疫小鼠。
主要发现
- 无佐剂生菜表达的S/preS121-47抗原按1 μg/剂口服3次即足以在小鼠中触发体液免疫应答。
- 所诱抗体在表达NTCP的感染系统(HepG2-NTCP细胞系)中能中和HBV感染。
- 该中和效率高于口服表达S蛋白的生菜免疫小鼠所诱抗体。
关键数值与推荐
- 口服免疫方案为1 μg/剂、共3次、无佐剂。
- 中和感染评估使用表达NTCP的HepG2-NTCP细胞系感染系统。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatitis B Virus (HBV) infection can be prevented by vaccination. Vaccines containing the small (S) envelope protein are currently used in universal vaccination programs and achieve protective immune response in more than 90% of recipients. However, new vaccination strategies are necessary for successful immunization of the remaining non- or low-responders. We have previously characterized a novel HBV chimeric antigen, which combines neutralization epitopes of the S and the preS1 domain of the large (L) envelope protein (genotype D). The S/preS121-47 chimera produced in mammalian cells and Nicotiana benthamiana plants, induced a significantly stronger immune response in parenterally vaccinated mice than the S protein. Here we describe the transient expression of the S/preS121-47 antigen in an edible plant, Lactuca sativa, for potential development of an oral HBV vaccine. Our study shows that oral administration of adjuvant-free Lactuca sativa expressing the S/preS121-47 antigen, three times, at 1 μg/dose, was sufficient to trigger a humoral immune response in mice. Importantly, the elicited antibodies were able to neutralize HBV infection in an NTCP-expressing infection system (HepG2-NTCP cell line) more efficiently than those induced by mice fed on Lactuca sativa expressing the S protein. These results support the S/preS121-47 antigen as a promising candidate for future development as an edible HBV vaccine.
引用
- Dobrica MO, Lazar C, Paruch L, et al. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice. Vaccine. 2018. PMID: 30082163. doi:10.1016/j.vaccine.2018.07.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。